Physicochemical Properties
| Molecular Formula | C16H13BN3O2F2-.H+ |
| Molecular Weight | 329.109 |
| Exact Mass | 329.114 |
| CAS # | 150173-78-7 |
| PubChem CID | 164577564 |
| Appearance | Brown to black solid powder |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 4 |
| Heavy Atom Count | 24 |
| Complexity | 662 |
| Defined Atom Stereocenter Count | 0 |
| SMILES | O=C([O-])CCC1=N2[B+3]([F-])([F-])[N-]3C(=CC=C3C4NC=CC=4)C=C2C=C1 |
| InChi Key | HEVJIRROVGECSJ-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C16H14BF2N3O2/c18-17(19)21-11(6-8-16(23)24)3-4-12(21)10-13-5-7-15(22(13)17)14-2-1-9-20-14/h1-5,7,9-10,20H,6,8H2,(H,23,24) |
| Chemical Name | 3-[2,2-difluoro-12-(1H-pyrrol-2-yl)-3-aza-1-azonia-2-boranuidatricyclo[7.3.0.03,7]dodeca-1(12),4,6,8,10-pentaen-4-yl]propanoic acid |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: This product requires protection from light (avoid light exposure) during transportation and storage. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| References |
[1]. Development of BODIPY Dyes With Versatile Functional Groups at 3,5-positions From Diacyl Peroxides via Cu(ii)-catalyzed Radical Alkylation. Chem Commun (Camb). 2019 Apr 16;55(32):4691-4694. |
Solubility Data
| Solubility (In Vitro) | DMSO : ~62.5 mg/mL (~189.91 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.08 mg/mL (6.32 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.08 mg/mL (6.32 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 3.0385 mL | 15.1925 mL | 30.3850 mL | |
| 5 mM | 0.6077 mL | 3.0385 mL | 6.0770 mL | |
| 10 mM | 0.3038 mL | 1.5192 mL | 3.0385 mL |